Shionogi Accelerates Development of Potential COVID-19 Treatments and Vaccine

In response to the novel coronavirus (SARS-CoV-2), Shionogi & Co., Ltd. (hereafter “Shionogi”), a pharmaceutical company with a major focus on infectious diseases, has joined the ranks of …
( read original story …)

---